The new age of liver transplantation

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 10, 1996, Pages 698-706

  Sheil, A G R ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Australia; Costs; Donors; Indications; Liver transplantation; Malignancy; Outcomes; Results

Indexed keywords

CYCLOSPORIN A;

AUSTRALIA; COST EFFECTIVENESS ANALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; REVIEW;

EID: 0029786992     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00721.x     Document Type: Review

References (65)

1. Calne RY, Rolles K, White DJG et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979; 2: 1033-6.
2. Starzl TE, Weil R III, Iwatsuki S et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg. Gynecol. Obstet. 1980; 151: 17-26.
3. National Institutes of Health Consensus Development Conference Statement: Liver Transplantation. June 20-23, 1983. Hepatology 1984; 4 (Suppl.): 107-10S.
4. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation, parts I and II. N. Engl. J. Med. 1989; 321: 1014-22, 1092-9.
5. Todo S, Demetris A, Makowska L et al. Primary non-function of hepatic homografts with pre-existing fatty infiltration. Transplantation 1989; 47: 903-5.
6. Tanaka K, Uemoto S, Tokunaga Y et al. Surgical techniques and innovations in living related liver transplantation. Ann. Surg. 1993; 217: 82-91.
7. Broelsch CE, Emond JC, Whitington PF et al. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts and living related segmental transplants. Ann. Surg. 1990; 212: 368-75.
8. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N. Engl. J. Med. 1990; 322: 1505-7.
9. De Ville de Goyet J. Split liver transplantation in Europe - 1988 to 1993. Transplantation 1995; 59: 1371-6.
10. Alexander JW, Vaughn WK. The use of marginal donors for organ transplantation: Influence of donor age on outcome. Transplantation 1991; 51: 135-9.
11. Rosengard AM, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. Transplantation 1995; 59: 1325-33.
12. Starzl TE, Valdivia LA, Murase N et al. The biologic basis of and strategies for clinical xenotransplantation. Immunol. Rev. 1994; 141: 213-44.
13. Starzl TE, Demetris AJ. Liver Transplantation. Chicago: Year Book Medical Publishers Inc., 1990; 137-9.
14. Information from the Combined Registry of the Australian Liver Transplant Centres. Current address: The Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia.
15. Ringe B, Pichlmayear R. Total hepatectomy and liver transplantation: A life-saving procedure in patients with severe hepatic trauma. Br. J. Surg. 1995; 82: 837-9.
16. Cardona J, Houssin D, Gauthier F et al. Liver transplantation in children with Alagille syndrome - a study of twelve cases. Transplantation 1995; 60: 339-42.
17. Raynor SC, Wood RP, Spanta AD, Shaw BW Jr. Liver transplantation in a patient with abdominal situs inversus. Transplantation 1988; 45: 661-3.
18. Chui AKK, Vass J, McCaughan GW, Sheil AGR. Giant cavernous hemangioma: A rare indication for liver transplantation. Aust. N.Z. J. Surg. 1996; 66: 122-4.
19. Holmgren G, Steen L, Ekstedt J et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-Met30). Clin. Genet. 1991; 40: 242-6.
20. Olivieri NF, Liu PP, Sher GD et al. Brief report: Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N. Engl. J. Med. 1994; 330: 1125-7.
21. Tzakis AG, Ricordi C, Alejandro R et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990; 336: 402-5.
22. Sheil AGR, Thompson JF, Stephens MS et al. Mesoportal graft for thrombosed portal vein in liver transplantation. Clin. Trans. 1987; 1: 18-20.
23. Tzakis A, Todo S, Stieber A et al. Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation 1989; 48: 530-1.
24. O'Grady JG, Alexander GJM, Hayllar KM et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
25. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failures: Definition and causes. Semin. Liver Dis. 1986; 6: 97-106.
26. Farges O, Kalil AN, Samuel D et al. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation 1995; 59: 1124-33.
27. Sheil AGR, McCaughan GW, Isai H, Hawker F, Thompson JF, Dorney SFA. Acute and subacute fulminant hepatic failure: The role of liver transplantation. Med. J. Aust. 1991; 154: 724-8.
28. Rozga J, Podesta L, Le Page E et al. A bioartificial liver to treat acute liver failure. Ann. Surg 1994; 219: 538-46.
29. Sussman NL, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif. Org. 1993; 17: 27.
30. Chari RS, Collins BH, Magee JC et al. Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. New Engl. J. Med. 1994; 331: 234-7.
31. Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayear R. Total hepatectomy and liver transplantation as two-stage procedure. Ann. Surg. 1993; 218: 3-9.
32. Makowka L, Cramer DV, Hoffman A. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654-9.
33. Boudjema K, Ciierqui D, Jaeck D et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 1995; 59: 218-23.
34. Kalayoglu M, Stratta RJ, Sollinger HW. Liver transplantation in infants and children. J. Pediatr. 1989; 24: 70-6.
35. Lebeau G, Yanaga K, Marsh JW et al. Analysis of surgical complications after 397 hepatic transplantations. Surg. Gynecol. Obstet. 1990; 170: 317-22.
36. Sheil AGR. Malignancy following liver transplantation - a report from the Australian Combined Liver Transplant Registry. Trans. Proc. 1995; 27: 1247.
37. Starzl TE, Demetris AJ. Liver Transplantation. Chicago: Year Book Medical Publishers Inc., 1990; 121-4.
38. Calne RY, Williams R. Liver transplantation. Curr. Probl. Surg. 1979; 16: 3-44.
39. Haug CE, Jenkins RL, Rohrer RJ et al. Liver transplantation for primary hepatic cancer. Transplantation 1992; 53: 2.
40. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J. Amer. Coll. Surg. 1995; 180: 1-9.
41. Marino IR, Todo S, Tzakis AG et al. Treatment of hepatic epitheloid hemangioendothelioma with liver transplantation. Cancer 1988; 62: 2079-84.
42. Makowka L, Tzakis AG, Mazzaferro V et al. Liver transplantation for metastatic endocrine tumors of the intestine and pancreas. Surg. Gynecol. Obstet. 1989; 168: 107-11.
43. Samuel D. Liver transplantation in European patients with hepatitis B surface antigen. N. Engl. J. Med. 1993; 329: 1842-7.
44. Campbell DA Jr, Rolles K, Jamieson N et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg. Gynecol. Obstet. 1988; 166: 511-18.
45. Donaldson PT, Alexander GJM, O'Grady J et al. Evidence for an immune response to HLA class I antigens in the vanishing-bile duct syndrome after liver transplantation. Lancet 1987; 1: 945-51.
46. O'Grady JG, Alexander GJ, Sutherland S et al. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent cofactors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; 2: 302-5.
47. Colonna JO, Shaked A, Gomes AS et al. Biliary strictures complicating liver transplantation. Ann. Surg. 1992; 216: 344-52.
48. Esquivel CO, Klintmalm G, Iwatsuki S et al. Liver transplantation in patients with patent splenorenal shunts. Surgery 1987; 101: 430-2.
49. Kalayoglu M, Sollinger WH, Stratta RJ et al. Extended preservation of the liver for clinical transplantation. Lancet 1988; 1: 617-19.
50. Terpstra OT, Reuvers CB, Schalm SW. Auxiliary heterotopic liver transplantation. Transplantation 1988; 34: 1003-7.
51. Margreiter R, Kramar R, Huber C et al. Combined liver and kidney transplantation. Lancet 1984; 1: 1077-8.
52. Starzl TE, Bilheimer DW, Bahnson HT et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382-3.
53. Wallwork J, Williams R, Calne RY. Transplantation of the liver, heart and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet 1987; 2: 182-5.
54. Starzl TE, Demetris AJ. Liver Transplantation. Chicago: Year Book Medical Publishers Inc., 1990; 141-5.
55. Takaya S, Bronsther O, Iwaki Y et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400-6.
56. Katz SM, Kimball PM, Ozaki C et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation 1994; 57: 616-20.
57. Donaldson PT, Thomson LJ, Heads A et al. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation: An assessment by cytotoxicity and flow cytometry. Transplantation 1995; 60: 1016-23.
58. Nikaein A, Backman L, Jennings L et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994; 58: 786-92.
59. Calne RY, Sella RA, Pena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-4.
60. Collins RH, Cooper B, Nikaein A, Klintmalm G, Fay JW. Graft-versus-host disease in a liver transplant recipient. Ann. Int. Med. 1992; 11: 391-2.
61. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism and graft acceptance. Lancet 1992; 339: 1579-82.
62. Fontes P, Rao AS, Demetris AJ et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 1994; 344: 151-5.
63. Starzl TE, Demetris AJ. Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA 1995; 273: 876-9.
64. McCaughan GW, O'Brien E, Sheil AGR. A follow up of 53 adult patients alive beyond 2 years following liver transplantation. J. Gastroenterol. Hepatol. 1993; 8: 569-73.
65. Levy MF, Jennings L, Abouljoud MS et al. Quality of life improvements at one, two and five years after liver transplantation. Transplantation 1995; 59: 515-18.